닥플 플러스
KALC International Conference 2026 -2일차
대한폐암학회
연수평점 :5점
오프라인
주관
대한폐암학회
교육일자
2026-09-11
수강료
100,000원
교육형태
오프라인
등록일시
2026-06-29
교육시간
6시간 20분
연수평점
5점
장소
서울특별시 잠실 롯데호텔 3층 크리스탈볼룸
교육종류
내과, 외과, 흉부외과, 영상의학과, 방사선종양학과, 결핵과, 진단검사의학과, 병리과, 가정의학과, 핵의학과
타임테이블
| 날짜 | 시간 | 강의명 | 강사 | 구분 |
|---|---|---|---|---|
| 2026-09-11 | 08:20~09:00 | From evidence to practice: Integrating TEVIMBRA into routine clinical practice | 안병철(국립암센터) | - |
| 2026-09-11 | 09:10~09:25 | Imaging Challenges in Lung Cancer Staging with ILD | 채금주(전북대병원) | - |
| 2026-09-11 | 09:25~09:40 | Risk Assessment and Preoperative Optimization for ILD Patients | Chi-Fu Jeffrey Yang(Massachusetts General Hospital, USA) | - |
| 2026-09-11 | 09:40~09:55 | Postoperative Management and Prevention of Acute Exacerbation | 유홍석(삼성서울병원) | - |
| 2026-09-11 | 09:55~10:10 | Pathological Perspective on Lung Cancer Arising in ILD | 김세희(삼성서울병원) | - |
| 2026-09-11 | 10:10~10:25 | Coffee Break | - | - |
| 2026-09-11 | 10:25~10:40 | Combatting acquired resistance in oncogene-driven lung cancer: From bench to bedside | Pasi A. Jänne (Dana-Farber Cancer Institute, USA) | - |
| 2026-09-11 | 10:40~10:55 | Cancer-Associated Fibroblasts and Extracellular Matrix Remodeling in Lung Cancer Progression | 안영호(이화의대) | - |
| 2026-09-11 | 10:55~11:10 | Assessment of Lung Cancer Evolution by Liquid Biopsy | Klaus Pantel (Univ. Medical Center Hamburg-Eppendorf, Germany) | - |
| 2026-09-11 | 11:10~11:25 | Genomic–transcriptomic evolution in lung cancer and metastasis | Thomas Jones (Univ. College London, UK) | - |
| 2026-09-11 | 11:25~11:40 | Coffee Break | - | - |
| 2026-09-11 | 11:40~12:20 | A Decade of Transformation in EGFRm NSCLC: Redefining the Standard of Care with Tagrisso | Pasi A. Jänne (Dana-Farber Cancer Institute, USA) | - |
| 2026-09-11 | 12:20~12:50 | KALC General Meeting | - | - |
| 2026-09-11 | 12:50~13:10 | The Evolution of Translational Research in Lung Cancer | David P. Carbone(Ohio State Univ., USA) | - |
| 2026-09-11 | 13:10~13:30 | Landmark Trials in SABR: From Early Stage to Oligometastasis | Joe Y. Chang(MD Anderson Cancer Center, USA) | - |
| 2026-09-11 | 13:30~13:50 | The Journey of Lung Cancer Therapy in Korea: Past, Present, and Future | 박근칠(삼성서울병원) | - |
| 2026-09-11 | 13:50~14:10 | Coffee Break | - | - |
| 2026-09-11 | 14:10~14:25 | Neoadjuvant Immunotherapy: Changing the Surgical Paradigm | Jonathan Spicer(McGill Univ., Canada) | - |
| 2026-09-11 | 14:25~14:40 | Impact of Neoadjuvant Therapy on Surgical Complexity | 나권중(서울대학교병원) | - |
| 2026-09-11 | 14:40~14:55 | Pathological Complete Response (pCR) and ctDNA as Endpoints | Kurt A. Schalper(Yale School of Medicine, USA) | - |
| 2026-09-11 | 14:55~15:10 | Clinical Decision Making: Neoadjuvant vs. Adjuvant Approaches | 강진형(Seoul St. Mary’s, Korea ) | - |
| 2026-09-11 | 15:10~15:20 | Coffee Break | - | - |
| 2026-09-11 | 15:20~15:35 | Beyond DLL3: Navigating Novel Strategies and Global Perspectives in Advanced SCLC | Kenneth O(Princess Alexandra Hospital, Australia) | - |
| 2026-09-11 | 15:35~15:50 | Evolutionary Trajectories of Small Cell Lung Cancer under Therapy | 안병철(국립암센터) | - |
| 2026-09-11 | 15:50~16:05 | Future Directions in Immunotherapy Combinations for SCLC | Feng-Ming Kong(Univ. of Hong Kong, Hong Kong) | - |
| 2026-09-11 | 16:05~16:20 | Unravelling the Molecular Spectrum of LCNEC: Implications for Treatment Selection | Anne-Marie Dingemans (Erasmus Medical Center Rotterdam, Netherlands)) | - |
| 2026-09-11 | 16:20~17:00 | Lazertinib as a New Standard for EGFRm+ NSCLC : Powerful as One, Stronger as Two | 정현애(삼성서울병원) | - |
비고
Early-bird: KALC Member100,000원/ Resident, Fellow, Trainee, Nurse, Army Doctor, Researcher, Others 50,000원 / Non-Member, Healthcare Professiona150,000원 사전등록비: 150,000원/100,000원/200,000원 현장등록비: 200,000원/150,000원/250,000원
문의처
담당자
김인정
연락처
02-741-8540
이메일
kalc@lungca.or.kr